Diabete Type 2Peel FDPPNCT07675551
Peel Family Diabetes Prevention Program
A study testing Family Dyad Health and Wellness Coaching Session and Educational Material in people with Diabete Type 2, run by Trillium Health Partners at 2 sites in Canada.
Trial summary
The goal of this Hybrid Type 2 effectiveness-implementation pilot randomized controlled trial is to assess the feasibility and preliminary effectiveness of a community-based wellness coaching intervention (the intervention) to prevent type 2 diabetes (T2D) among South Asian (SA) and Black African and Caribbean (BAC)… Read more about this study
- Who is it for?
- Ages 14 years and olderHealthy volunteers can take part
- Conditions the study is for
- Diabete Type 2
- What is being tested?
- Family Dyad Health and Wellness Coaching Session and Educational Material
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 140 participants
- Where
- 2 sitesCanada
- Study dates
- 20 May 2026to 30 Sep 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 14 years and older
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- Study participants will consist of a self-identified primary family caregiver aged 18 years or older with children under 25 year of age living in the same household. Optional youth family member aged 14 to 25 years at the time of study entry are welcome but not mandatory. The primary family caregiver will serve as the primary (index) research participant for the study and should have the following inclusion criteria:
- Self-identifies as either South Asian or Black, African and Caribbean.
- Lives in the Peel Region (Mississauga, Brampton or Caledon), Ontario, Canada.
- Be 18 years or older and have children aged 25 years or under in the same household. AND
- Have no medical diagnosis (self-reported) of diabetes.
- Have no medical diagnosis (self-reported) of prediabetes that requires any medical or pharmacological treatment.
- Have a blood-based sugar lower than or equal to 6.5 measured through the hemoglobin A1c test using a finger prick at the pre-enrollment assessment visit. AND
- The family caregiver and optional youth (when participating) must be proficient in English (reading, writing, and speaking), as English will be the primary language used for the participation eligibility, implementation, delivery, and evaluation of the intervention.
Who cannot join
- Do not meet all the criteria above.
- A medical condition or health professional has advised them not to engage in physical activity of any type, or they are following a specific diet.
- Cannot give informed consent to participate voluntarily in the intervention and study.
Trial locations and contacts
2 sites in 1 country. Contact the study team or a site near you to ask about taking part.
Cilia Mejia-Lancheros (Study Research Lead), RN, MPH, Msc. GHP, PhD contact
Canada2 sites, 2 recruiting
- Recruiting
Wellfort Community Health Services
Brampton, Ontario, L6T 3J1
Hamna Khan, MPP, 437-231-6951, hamna.khan@thp.ca
Ian Zenlea, MD, MPH
- Recruiting
Punjabi Community Health Services (PCHS)
Brampton, Ontario, L6T 3T6
Hamna Khan, MPP, hamna.khan@thp.ca
Ian Zenlea, MD, MPH
About this study
Official title: Peel Family Diabetes Prevention Program (Peel FDPP): Family-Centred Health and Wellness Coaching Pilot Randomized Controlled Trial
The goal of this Hybrid Type 2 effectiveness-implementation pilot randomized controlled trial is to assess the feasibility and preliminary effectiveness of a community-based wellness coaching intervention (the intervention) to prevent type 2 diabetes (T2D) among South Asian (SA) and Black African and Caribbean (BAC) communities in the Peel region of Ontario, Canada. The study evaluates the impact of the intervention on reducing diabetes risk and related intermediate outcomes, including biomarkers, anthropometric measures, well-being, knowledge, health behaviours, and family-level outcomes in the study participants.
Study's SA and BAC participants will consist of a primary adult family caregiver aged 18 years or older, who does not have T2D and is not taking pharmacological treatment for blood glucose reduction, and who has children aged 25 or under living in the same household. If the Family caregiver has youth children aged 14 to 25 years residing in the same household, who want to participate in the study, they are welcome to join it but not mandatory. The study aims to generate preliminary evidence on both the implementation and effectiveness of the intervention over a six-month per person period. The overall duration of the study (implementation, effectiveness monitoring an evaluation) will be up to 16 months, from the the start of recruitment in May 2026 to the September 2027, where the intervention delivery for the last participant enrolled in the study will expected to be completed.
Read more
Family caregiver participants of each ethno-cultural group (SA and BAC) will be randomly assigned to either the intervention or control arm. During the first six months, participants in the intervention arm will receive biweekly health and wellness coaching delivered by trained community-based coaches, optional group coaching sessions with other participants, weekly motivational messages, and an educational T2D prevention booklet. Participants in the control arm will receive only the educational T2D prevention booklet.
Implementation and effectiveness outcomes will be assessed using a mixed-methods approach, integrating qualitative and quantitative data collected at baseline and at the 6-month post-randomization time point. This approach is intended to generate comprehensive, preliminary evidence on both the implementation and effectiveness components of the health and wellness intervention. Quantitative and mixed-methods analyses will be conducted to provide an integrated understanding of the implementation and effectiveness outcomes studied.
Findings from this pilot trial will inform the design of larger, definitive studies to better assess impact and guide future escalation and/or adaptation.
Results will be disseminated in multiple formats and tailored to diverse audiences, including community partners, local communities, social media, referral pathways, academics, researchers, and decision-makers.
Read the detailed description
Background: Communities from South Asian (SA) and Black African and Caribbean (BAC) backgrounds in the Peel region of Ontario, Canada, experience disproportionately high rates of type 2 diabetes (T2D). The high prevalence of T2D in these communities is driven by a complex set of interrelated factors, including biological predisposition, environmental, and social/behavioural influences, all of which are shaped by social determinants at the societal, system, area, and individual levels. Based on existing collaborative research conducted in these populations in Peel, as well as input from diverse community partners and Peel organizations serving SA and BAC communities, there is a clear need for more family-focused programming to prevent T2D in these communities, particularly community-led and culturally sensitive approaches.
Objective: To assess the intervention's preliminary implementation and effectiveness. Findings will inform future adaptation of the health and wellness coaching T2D prevention model and support scale-up in larger implementation and effectiveness studies.
Methods: In partnership with local Peel-based community organizations, the research team will recruit 70 SA family (plus optional youth) and 70 BAC family caregivers (plus optional youth) to participate in a Hybrid Type 2 Effectiveness-Implementation Pilot Randomized Controlled Trial (RCT) with a six-month person-level follow-up post-randomization and a mixed-methods approach. Of the 70 participating caregivers (plus optional youth) in each community group, 70 will be randomly allocated (1:1) to the intervention group and 70 to the control group. The overall study duration will be 22 months, spanning from participant recruitment through to completion of primary implementation and effectiveness outcome reporting.
Family caregiver participants (family caregiver plus optional youth) in the intervention group will receive tailored, human-delivered health and wellness coaching for the T2D prevention program over six months, where they will receive biweekly diabetes-focused coaching sessions, supplemented by a monthly group-based coaching session. The intervention group will also receive a co-designed educational booklet on diabetes prevention and a weekly short motivational coaching reminder (via email or text, depending on participant preferences). At the end of the six-month coaching follow-up, participants will complete the study through a coaching closeout assessment session conducted by the team coaches.
The participant in the control group (family caregiver plus optional youth) will receive the same co-designed diabetes prevention booklet as the intervention group but will not receive additional coaching support during the six-month follow-up period. At the end of the person follow-up period, control participants will conclude their participation in the study by completing a survey-based assessment of T2D goal attainment, administered by research team staff.
Primary co-implementation outcomes will include acceptability, appropriateness, reach, adoption (uptake), availability, and fidelity. These outcomes will be assessed through semi-structured qualitative interviews conducted by research staff, supplemented with brief survey-based measures. Reach will be assessed from baseline through the recruitment period, while all other outcomes will be measured at 6 month post-randomization.
Co-effectiveness primary outcomes will include hemoglobin A1c (HbA1c) and quality of life measures. Secondary outcomes will include goal-achievement progress, diabetes knowledge, biomarkers (lipid panel), blood pressure, body weight and adiposity, dietary behaviours, cooking practices, diet-related self-efficacy, healthy food intake patterns, and physical activity, sleep duration, quality, satisfaction, and environmental influencing factors; mental well-being state; perceived stress; resilience; and family functioning. Tertiary outcomes will include the intervention's impact on family well-being. Objective measures (biomarkers, blood pressure, body weight, and adiposity) will be collected in person by research staff at enrolment (T1) and 6 months (T2). All remaining outcomes will be assessed using self-administered surveys with validated scales, structured questions, and qualitative open questions at baseline (T1) and 6 months (T2) from the randomization date.
The investigators will use a mixed-methods, cross-sectional and longitudinal (when applicable) convergence-analytical approach to integrate quantitative and qualitative data and, when possible, identify areas of convergence, complementarity, or divergence across implementation and effectiveness outcomes. Primary effectiveness outcomes will be analyzed using an intention-to-treat approach, accounting for repeated measures and interdependence within family dyads (when family caregiver and optional youth) when applicable, and variation in person-time follow-up. The investigators will estimate and report observed effect sizes, along with their corresponding 95% confidence intervals, for all outcomes using descriptive statistics and mixed-effects models or Generalized Estimating Equations, when appropriate. Secondary analyses will further explore potential complex, interrelated associations between implementation and effectiveness outcomes, as well as the influence of socio-demographic and other factors on these relationships. For qualitative data, the investigators will apply one point or Qualitative Longitudinal Research (when two points data are available) approaches to analyze repeated qualitative data collected for both implementation and effectiveness components. Finally, the investigators will conduct a mixed-methods analysis, integrating findings from both qualitative and quantitative strands to assess their alignment, divergence, or complementarity.
Findings: Both implementation and effectiveness findings will be reported, contributing important evidence on the feasibility, delivery and impact of the piloted health and wellness coaching intervention for T2D prevention among SA and BAC family caregiver plus optional youth (when applicable). These findings will help assess future study feasibility, refinements to the intervention model and implementation approach, as well as provide preliminary estimates of potential impact across primary, secondary, and tertiary health-related indicators. Investigators will also assess whether the proposed theory of change is supported, specifically whether the intervention contributes to reducing T2D risk and improving quality of life by supporting participant- and family-tailored diabetes prevention goals, and whether it influences intermediate drivers of T2D risk.
Conclusion: The findings and methodological approach of the pilot-tested proposed intervention will guide the design of larger-scale implementation and effectiveness studies across the same or different communities and settings to further assess its real impact on reducing T2D risk and the main driving factors associated with it.
- Conditions
- Diabete Type 2
- Being tested
- Family Dyad Health and Wellness Coaching Session, Educational Material
- Keywords
- Diabetes Risk, Diabetes, Coaching, Intervention, Implementation, Effectiveness, Family, Diet Habits, Physical Activity, Mental Well-being, Health Behaviors
- Medical subject headings
- Diabetes Mellitus, Type 2, Diabetes Mellitus, Feeding Behavior, Motor Activity, Psychological Well-Being, Health Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Family Dyad Health and Wellness Coaching SessionBehavioural
Biweekly health and wellness coaching sessions (in-person or virtual) for type 2 diabetes, provided by trained community-based coaches. The maximum session length will be 30 minutes, with no mandatory minimum. Coaches will also share a short weekly motivational message, delivered to participants' phones or emails, depending on preferences. The intervention group participants may join an optional monthly group-based health and wellness coaching session with other program participants. Group sessions will be approximately 2 hours in length.
Educational MaterialBehavioural
A printed or digital educational booklet on type 2 diabetes (T2D) prevention. The booklet contains information related to the causes and signs of T2D, diet and physical activity engagement activities, mental well-being enhancement and stress management, strategies to set up positive lifestyles and behavioural change, along with a list of local health and social support services that may be used to further promote overall well-being and support T2D risk reduction.
| Study group | Role | What they receive |
|---|---|---|
| Diabetes-Prevention Health and Wellness Coaching | Experimental | Family caregiver participants (family carrgiver plus optional youth) will take part in an active health and wellness coaching program type 2 diabetes (T2D) prevention, delivered over six-month. Participants will receive 1) biweekly health and wellness coaching sessions (in-person or virtual) provided by trained community-based coaches (maximum session length will be 30 minutes); 2) Receive a short weekly "motivational message" which will be delivered to their phone or email; 3) Join optional monthly group-based health and wellness coaching sessions with other program participants (session length will be 2 hours); and 4) Receive an educational booklet for T2D prevention. Receives: Behavioral: Family Dyad Health and Wellness Coaching Session; Behavioral: Educational Material |
| Diabetes-Prevention Booklet | Active comparator | Participants (family caregivers plus optional youth) will receive the same educational type 2 diabetes (T2D) prevention booklets as the Diabetes-Prevention Health and Wellness Coaching group. Participants from the Diabetes-Prevention Booklet group will be asked to use the T2D educational booklet at their own pace, set up their own T2D prevention goals, and independently access available health promotion, diabetes prevention, and social support services listed in the workbook throughout the 12-month study period.
The Diabetes-Prevention Booklet group will not receive coaching sessions, motivational messages, group-based coaching sessions, or any additional diabetes-related guidance from the study's intervention coaches or research team. Receives: Behavioral: Educational Material |
What is being measured
The primary outcome is the main question the study is designed to answer.
Implementation Outcome: Intervention Acceptability
Definition: The perception among our intervention participants (SA and BAC) and coaches that the delivery of the intervention curriculum is agreeable, palatable, or satisfactory.
Level and unit of analysis: At the provider (coaches) and study participant level.
Measure: Level of rating and perceived intervention's approval, appeal, likeness, and welcoming.
Data will be collected from intervention participants and study coaches using semi-structured interviews and surveys. Interviews will use open-ended questions to explore perceived acceptability, including appropriateness, appeal, likeability, and a sense of welcome. Acceptability will also be measured using the 4-item Acceptability of Intervention Measure (AIM), rated on a 5-point Likert scale ranging from 1 (completely disagree) to 5 (completely agree), with higher scores indicating greater acceptability.
Measured: Six months post-randomization.
Implementation Outcome: Intervention Appropriateness
Definition: The perceived fit, relevance, or compatibility among our intervention participants and coaches (frontline intervention providers) of the intervention content and format in addressing their needs for T2D prevention associated with T2D risk factors.
Level and unit of analysis: At the provider (coaches) and study participants' level.
Measure: Level of rating and perceived fit, relevance, compatibility, suitability, and usefulness.
Data collection and instruments: Data collected through individual semi-structured interviews and surveys. Interviews will explore perceived fit, relevance, compatibility, suitability, usefulness and practicality of the intervention content and format. The survey includes a 4-item Acceptability scale with a 1-5 score (1 = Completely disagree, 2 = Disagree, 3 = Neither agree nor disagree, 4 = Agree, 5 = Completely agree), as well as qualitative questions.
Measured: Six months post-randomization.
Implementation Outcome: Intervention Reach
Definition: The proportion of and representation of the targeted SA and BAC participants in the intervention.
Level and unit of analysis: At the study participant level. Measure: Reach rates and related factors. Data collection and instruments: Measured as the reach rate of the targeted population (percentage of eligible families with children aged 25 years or under in Peel of BAC and SA communities that were enrolled in the study), and the percentage of representativeness of the enrolled participants in relation to the SA and BAC population as related to socio-demographic and T2D risk.
Qualitative questions exploring drivers of participation will be assessed at screening and enrolment using the expression of interest form, eligibility assessment form, and/or consent form. For example, participants will be asked: "What motivated you to participate in this study?"
Measured: Baseline.
Implementation Outcome: Intervention Adoption (Uptake)
Definition: The decision or effort to begin using/implementing the plans/advice from the coaches.
Level and unit of analysis: At the study participant level. Measure: Level of rating and perceived intervention's approval, appeal, likeness, and welcoming.
Data collection and instruments: Quantitative measures will include enrolment rates; initial uptake (defined as the proportion of intervention participants and family dyads attending at least two sessions within the first month of enrolment); uptake at the end of the active intervention stage; and uptake at the end of the sustainability stage. Qualitative data will be collected through interviews using open-ended questions to explore reasons for enrolment, initiation of the health and wellness T2D coaching intervention, and factors influencing participation, adherence, and completion.
Measured: Six months post-randomization.
Implementation Outcome: Intervention Availability
Definition: The extent to which the intervention is supplied and accessible at any given time.
Level and unit of analysis: At the provider (coaches) and study participant level.
Measure: Level of availability and perceived accessibility. Data collection and instruments: Data will be obtained from quantitative measures derived from study and intervention delivery logs at the coach and site levels, as well as from individual semi-structured interviews (accessibility perceptions and driving factors) with the study's intervention coaches and participants in the intervention group.
Examples of specific measures: 1) Percentage of participants able to access a session within the first month of enrolment (randomization); 2) Attendance rates at scheduled sessions; 3) Percentage of participants reporting satisfaction with program availability; and 4) Number of last-minute cancellations by participants (participant-related diverse reasons).
Measured: Six months post-randomization.
Implementation Outcome: Intervention Fidelity
Definition: The degree to which the intervention was consistently implemented as planned.
Level and unit of analysis: At the provider (coaches) and study participant level.
Measure: Level of fidelity and driving factors. Data collection and instruments: Quantitative/qualitative measures using intervention delivery logging, fidelity checklist, audio-recorded coaches' sessions, and semi-structured interviews. Measures include 1) A self-fidelity score (based on a self-reported fidelity checklist collected after each coaching session). 2) External-fidelity monitoring. A trained independent assessor will also evaluate intervention delivery logs and a sample (10-20%) audio-recorded coaching sessions to determine a fidelity score on a 0-100 scale for the following dimensions: a) Adherence /Content delivered, b) Dose/Dose delivered and received; and c) Coaching Delivery Quality (competence delivery).
Measured: Six months post-randomization.
Effectiveness Outcome: T2D Risk
Measure: 1)Capillary Blood Hemoglobin A1C (%), measured using Point-of-care (POC) A1C testing.
Assessment participant unit: Adult family caregiver participants and optional youth participants.
Analytical level: 1) As a quantitative (continuous) outcome measure (%); and 2) as a clinically significant range (Non-prediabetic (non-prediabetic diabetic): A1C <6.0%. Prediabetes: A1C between 6.0% and <6.5%. Diabetes: A1C > 6.5%).
Measured: Baseline and six months post-randomization.
Effectiveness Outcome: Overall Quality of Life
Measure: 1) Overall quality of life (QoL) will be assessed using the EQ-5D-5L tool. The EQ-5D-5L measures five dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression), each rated on a 5-level scale (1 = no problems to 5 = extreme problems).
Assessment participant unit: Adult family caregiver participants and optional youth participants.
Analytical level: 1) The EQ-5D-5L overall health index score. 2) The EQ-5D-5L dimension-specific scores.
Measured: Baseline and six months post-randomization.
Effectiveness Outcome: Health-Related Quality of Life
Measure: It will be measured using the EQ VAS, whose values range from 0 to 100, reflecting overall health (0 = worst imaginable health; 100 = best imaginable health).
Assessment participant unit: Adult family caregiver participants and optional youth participants.
Analytical level: Overall health rated score of the EQ VAS.
Measured: Baseline and six months post-randomization.
Effectiveness Outcome: Health-attached QoL Meaning and Perceptions
Measure: The perceived level of health-related quality of life (QoL) will be assessed using qualitative questions, such as:
- When you think about health, what does it personally mean to you, and how does that meaning relate to the number you selected on the health scale (EQ-VAS)?
- Can you explain why you chose that number on the health scale (EQ-VAS) today?
- What aspects of your health, daily life, or overall well-being influenced your rating? Assessment participant unit: Adult family caregiver participants and optional youth participants.
Analytical level: Salient findings will be derived from qualitative data.
Measured: Baseline and six months post-randomization.
Effectiveness Outcome: Happiness
Measure: 1) Well-being will be assessed using the VAS-Happiness Scale, with a value range of 0 to 100 (0 = completely unhappy, 100 = completely happy). 2) A qualitative happiness assessment using open-ended questions will complement the VAS-Happiness Scale, exploring participants' perceptions of the meaning and interpretation of VAS-Happiness Scale score selection.
Assessment participant unit: Adult family caregiver participants and optional youth participants.
Analytical level: 1) Overall VAS-Happiness score; and 2) Salient qualitative happiness themes (definition and driving scoring factors).
Measured: Baseline and six months post-randomization.
Effectiveness Outcome: Happiness Meaning and Perceptions
Measure: It will be assessed using qualitative questions to help participants contextualize their happiness rating level and express their unique perceptions. Qualitative questions that will be used are as follows: 1) When you think about happiness, what does it personally mean to you, and how does that meaning relate to the number you selected on the scale? 2) Can you describe what influenced your rating on the happiness scale today? Assessment participant unit: Adult family caregiver participants and optional youth participants.
Analytical level: Salient happiness definition and driving scoring factors.
Measured: Baseline and six months post-randomization.
Secondary outcomes (25)
Effectiveness Outcome: Diabetes Prevention Knowledge
Measure: 1) Diabetes Prevention Knowledge level for the "Causes" and "Duration" of diabetes using the Diabetes Knowledge Questionnaire (DKQ). The DKQ dimension questions are rated using a three-response format: true (T), false (F), and don't know (DK). A score with a range of 0-100 will be calculated using the following formula: Number of correct responses /maximum possible score in that dimension, multiplied by 100.
Assessment participant unit: Adult family caregiver participants and optional youth participants.
Analytical level: At the dimension-specific score.
Measured: Baseline and six months post-randomization.
Effectiveness Outcome: Intervention Contribution to Diabetes Knowledge
Measure: It will be measured using qualitative open-ended questions such as follows:
- Since participating in this program, what new information have you learned about T2D that you didn't know before?
- Has your awareness of how to manage or prevent diabetes improved? If yes, in what ways?
- Which aspects of diabetes prevention (e.g., diet, exercise, stress management, seek help) do you feel more confident about now compared to before the intervention? 3) Have your attitudes or intentions toward diabetes prevention changed due to your participation in this program?
Assessment participant unit: Adult family caregiver participants and optional youth participants.
Analytical level: Salient drivers of diabetes prevention knowledge will be identified from the qualitative data.
Measured: Six months post-randomization.
Effectiveness Outcome: Lipids
Measure: The lipid panel will include total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), and non-high-density lipoprotein-cholesterol (non-HDL-C). It will be obtained using the participant's capillary blood (finger-prick) sample with a validated Point-of-Care (POC) device.
Assessment participant unit: Adult family caregiver participants and optional youth participants.
Analytical level: 1) Quantitative (continuous) outcome measure (mm/L) for each of the lipid panel components (TC, HDL, LDL, TG, non-HDL). 2) As a clinically significant range (category) according to the 2021 Canadian Cardiovascular Society Guidelines using the Framingham Risk Score (FRS) stratification and paediatrics guidelines.
Measured: Baseline and six months post-randomization.
Effectiveness Outcome: Blood Pressure
Measure: Three blood pressure (SBP) and diastolic blood pressure (DBP) measurements will be taken using a digital blood pressure device.
Assessment participant unit: Adult family caregiver participants and optional youth participants.
Analytical level: As continuous measures, the average systolic blood pressure (SBP, mmHg) and diastolic blood pressure (DBP, mmHg) were calculated from three readings. Then, the optimal blood pressure level will be analyzed by categorizing SBP and DBP values into clinically significant ranges according to the Hypertension Canada Guidelines (2025): Optimal blood pressure is defined as the mean of three readings: <130 (SBP)mmHg/80 (DBP) mmHg.
Measured: Baseline and six months post-randomization.
Effectiveness Outcome: Body Weight
Measure: Body weight (kg) will be measured by the research team rather than self-reported, using a validated weighing scale.
Assessment participant unit: Adult family caregiver participants and optional youth participants.
Analytical level: As a continuous outcome (kg).
Measured: Baseline and six months post-randomization.
Effectiveness Outcome: Waist Circumference
Measure: It will be measured with a waist circumference tape (cm) by a trained team member following WHO STEPS procedures.
Assessment participant unit: Adult family caregiver participants and optional youth participants.
Analytical level: The obtained WC values will be analyzed as a continuous variable for all participants and as a categorical variable for participants aged 18 or older (Low-risk WC and High-risk WC).
Measured: Baseline and six months post-randomization.
Effectiveness Outcome: Body Mass Index
Measure: It will be derived from body weight (kg) and height (m) measurements to obtain Body Mass Index (BMI) in kg/m². Height will be measured using a mobile height-measurement stadiometer by our trained research team, following WHO STEPS procedures. The weight measure has been explained in the weight-level outcome.
Assessment participant unit: Adult family caregiver participants and optional youth participants.
Analytical level: BMI will analyzed as continuous variable , as well as categoric weight variable as follows: Normal (BMI ≥18.5- 24.9 kg/m²), Overweight (BMI ≥ 25- 29.9 kg/m²), Obese (BMI ≥ 30 kg/m²)for participants aged 18 or older. For participants under 18 years, BMI will be categorized into weight status groups (possibly underweight, healthy weight, possibly overweight, possibly obese) based on children's age and sex WHO growth charts (ages 2 to 19) for Canada.
Measured: Baseline and six months post-randomization.
Effectiveness Outcome: Diet Cooking Practices Behaviours
Measure: A five-point Likert scale, ranging from always=5 to never =1, of their healthy cooking practice behaviours in the last week, using the following questionnaire:
- Does not add salt to food at the table
- Replaces salt with herbs and spices
- Replaces shortening/lard with vegetable oil
- Modifies recipes to lower sugar or fat
- Modifies recipes to increase fibre
- Uses healthy cooking methods (e.g., baking, grilling, steaming, or air frying) instead of deep frying
- Adds extra vegetables to casseroles and soups
- Plans meals using MyPlate method (or other meal planning methods) to include balanced and nutritious
- Checks nutrition facts label on food packages
- Prepares meals and snacks at home Assessment participant unit: Adult family caregiver participants and optional youth participants.
Analytical level: Item-level scores (1-5). Responses of "sometimes" to "always" will be recoded as 1(yes) and "rarely" or "never" as 0(no), then summed in a total score (0-10).
Measured: Baseline and six months post-randomization.
Effectiveness Outcome: Healthy Food Preparation Driven Factors
Measure: It will be assessed using the following qualitative questions:
- What kinds of challenges or barriers, if any, have you [your family caregiver for youth, if they do not cook] experienced when trying to cook healthy meals at home? 2) Has the program helped you [ your family caregiver for youth, if they do not cook], find ways to overcome some of these barriers? 3) How have your family's preferences or cultural traditions influenced the way you [your family caregiver for youth is they do not cook] cook or the changes you've made since the program? 4) Have you found ways to make traditional dishes healthier? Assessment participant unit: Adult family caregiver participants and optional youth participants.
Analytical level: Salient food preparation driven factors.
Measured: Baseline and six months post-randomization.
Effectiveness Outcome: Self-efficacy in Cooking
Measure: It will be measured using the following question: How confident do you feel in your ability [or your family caregiver's ability for youth if they do not cook] to prepare healthy meals regularly? The response options will be rated on a 5-point Likert scale: Not at all confident (1); Slightly confident (2); Moderately confident (3); Very confident (4); Extremely confident (5).
Assessment participant unit: Adult family caregiver participants and optional youth participants. As self-efficacy cooking score, range 1 to 5.
Measured: Baseline and six months post-randomization.
Effectiveness Outcome: Factors Influencing Cooking Self-efficacy
Measure: It will be measured using the following qualitative questions: 1) Can you describe what makes you feel confident [or your family caregiver's ability for youth if they do not cook] or not confident in preparing healthy meals regularly? 2) How does your confidence [or your family caregiver's ability for youth, if they do not cook] in meal preparation affect your family's eating habits or routines? 3) Have you noticed any changes over time in your confidence [or your family caregiver's ability for youth, if they do not cook] and what contributed to those changes? 4) How have your family members responded to these changes? Assessment participant unit: Adult family caregiver participants and optional youth participants.
Analytical level: Salient driving factors for self-efficacy in cooking.
Measured: Baseline and six months post-randomization.
Effectiveness outcome: Healthy Food Intake
Measure: Healthy food intake patterns. It will be assessed using the MyPlate method over a week (more than 3 days), in which participants self-report typical eating patterns following MyPlate recommendations (half the plate filled with non-starchy vegetables, a quarter of the plate filled with carbohydrate foods, and a quarter of the plate filled with protein foods), other foods, and beverage intake.
Assessment participant unit: Adult family caregiver participants and optional youth participants.
Analytical level: As categorial intake patterns (%) and count-based intake frequency (0,1,2,3…) of non-starchy vegetables, carbohydrate foods, protein foods, beverages, and other foods. Beverage intake type and frequency (number of glasses).
Measured: Baseline and six months post-randomization.
Effectiveness Outcome: Driving Factors of Healthy Foods Intake Patterns
Measure: It will be measured using the following questions:
- What are the main reasons you were not able [or able] to follow the MyPlate food intake recommendations (for example, filling half your plate with vegetables, one-quarter with carbohydrates, and one-quarter with protein)? Lack of time to prepare balanced meals.
- Limited access or affordability of healthy foods.
- Cultural or taste preferences.
- Lack of knowledge or cooking skills.
- Family or household food preferences. __Other (please specify)________________ Assessment participant unit: Adult family caregiver participants and optional youth participants.
Analytical level: Salient driving factors of healthy food intake.
Measured: Baseline and six months post-randomization.
Effectiveness Outcome: Physical Activity
Measure: Physical activity engagement level will be evaluated using the Physical Activity Vital Sign (PAVS) 2-item tool.
Assessment participant unit: Adult family caregiver participants and optional youth participants.
Analytical level: Weekly physical activity engagement level as a continuous measure: Total minutes of physical activity /week (minutes/week). Additionally, physical activity engagement will be categorized as a clinically significant variable based on the World Health Organization (2020) guidelines on physical activity and sedentary behaviour for adults (≥18 years) as low (< 150 of average minutes/week) or high (≥150 of average minutes /week), and for children (<18 years) as low (< 60 of average minutes minutes/day, or <420 minutes/week) or high (≥60 of average minutes minutes/day, or ≥420 minutes/ week).
Measured: Baseline and six months post-randomization.
Effectiveness Outcome: Driving Factors of Physical Activity Engagement
Measures: It will be assessed using the following qualitative open-ended questions:
- What makes it difficult [easy] for you to engage in regular physical activity?
- Can you describe any personal, economic, social, or environmental factors that limit [ encourage] your activity? 3) Are there specific programs, spaces, or tools that make it easier for you to exercise? 4) In what ways has engagement in the prevention program impacted your engagement in physical activity on a regular basis? Assessment participant unit: Adult family caregiver participants and optional youth participants.
Analytical level: Salient barriers to physical activity and categorical type of influencing factors, as well as perceived impact of the intervention in enhancing physical activity.
Measured: Baseline and six months post-randomization for questions 1 to 3. Six months post-randomization for question 4.
Effectiveness Outcome: Sleep Duration Behaviour
Measure: Sleep duration will be measured using the adapted 24-hour sleep duration question used in the National Longitudinal Study of Adolescent to Adult Health Parent Study. How many hours of sleep do you typically get each day? [HH:MM]. The question has been adapted to assess sleep duration patterns between the typical work or school day and the non-work or non-school day.
Assessment participant unit: Adult family caregiver participants and optional youth participants.
Analytical level: Total minutes of sleep duration (minutes/week), as well as sleep duration on workday/school days (minutes/week) and on weekend days (minutes/week).
Measured: Baseline and six months post-randomization.
Effectiveness outcome: Sleep Quality, Satisfaction, Environmental Influential Factors
Measures: It will be assessed using qualitative questions as follows. Workdays/schooldays Sleeping: 1)How would you describe the overall quality of your sleep on workdays or school days? 2) How satisfied are you with the amount and quality of sleep you typically get during workdays or school days? 3) Are there any environmental factors (e.g., noise, light, temperature, or household distractions) that affect your ability to get sufficient sleep during workdays or school days? Non-workday or Non-school Days: 1) How would you describe the overall quality of your sleep on weekend days? 2) How satisfied are you with the amount and quality of sleep you typically get during the weekend days? 3) Are there any environmental factors (such as noise, light, temperature, household environment) that affect your ability to get sufficient sleep during the weekend? Assessment participant unit: Adult family caregiver participants and optional youth participants.
Analytical level: Salient factors.
Measured: Baseline and six months post-randomization.
Effectiveness outcome: Mental/Emotional Well-Being
Measure: It will be measured using the 14-item Warwick-Edinburgh Mental Well-being Scale (WEMWBS), in which each item is rated on a 5-point Likert scale (1 = One of the time, 2 = Rarely, 3 = Some of the time, 4 = Often, 5 = All of the time).
Assessment participant unit: Adult family caregiver participants and optional youth participants.
Analytical level: As the total WEMWBS score, and as a categorical: Meaningful improvement (defined as an increase of ≥3 points from baseline) and Non-meaningful improvement (an increase of less than <3 points from baseline).
Measured: Baseline and six months post-randomization.
Effectiveness Outcome: Driving Factors of Mental Well-being
Measure: It will be assessed using qualitative open-ended questions, as follows:
- What kinds of experiences, relationships, social/cultural influence or daily activities have the greatest positive impact on your mental well-being?
- Can you describe any challenges or situations that make it harder for you to feel mentally/emotionally well or maintain a positive outlook?
- What supports, resources, or community connections help you the most in maintaining or improving your mental well-being?
- Have there been any changes in your mental well-being recently? Do you think participating in this community and research-informed study has contributed positively [or negatively] to your mental well-being changes? Assessment participant unit: Adult family caregiver participants and optional youth participants.
Analytical level: Salient driving factors of mental well-being.
Measured: Baseline and six months post-randomization for questions 1 to 3. Six months post-randomization for question 4.
Effectiveness Outcome: Perceived Stress
Measure: It will be measured using the Perceived Stress Scale (PSS-10), a 10-item questionnaire assessing feelings and thoughts over the past month on a 5-point Likert scale (0 = never to 4 = very often).
Assessment participant unit: Adult family caregiver participants and youth participants.
Analytical level: The total score of the PSS-10, and as perceived stress categories (constructs) scores: a) Perceived helplessness total score, and b) Perceived self-efficacy total score.
Measured: Baseline, six months post-randomization, and twelve months post-randomization
Effectiveness Outcome: Driving Factors of Stress
Measure: It will be assessed using qualitative, open-ended questions, such as follows:
- Can you describe the main things in your life that currently cause you stress or make you feel overwhelmed?
- Who or what supports you the most when you are feeling stressed (e.g., people, activities, places, beliefs)?
- How do your surroundings, such as school, work, family, or community, affect your stress levels?
- Have you noticed any changes in what causes you stress or how you handle it over time?
- Do you think the intervention you are participating in contributed to these changes? Assessment participant unit: Adult family caregiver participants and optional youth participants.
Analytical level: Salient driving factors of perceived stress.
Measured: Baseline and six months post-randomization for questions 1 to 3. Six months post-randomization for questions 4 and 5.
Effectiveness outcome: Resilience
Measure: Measured using 1) the Connor-Davidson Resilience Scale (CD-RISC-2), 2-item version, rated on a 5-point Likert scale (0 = Not true at all, 1 = Rarely true, 2 = Sometimes true, 3 = Often true, 4 = True nearly all the time).
Assessment participant unit: Adult family caregiver participant and optional youth participant.
Analytical level: Total score of the CD-RISC-2.
Measured: Baseline and six months post-randomization.
Effectiveness Outcome: Driving Factors of Resilience
Measure: Driving factors of resilience related to self-perception of resilience, learning from challenges, and resilience support/connections will be assessed using the following qualitative open-ended questions:
- How would you describe your ability to bounce back from setbacks, and what do you think makes you resilient?
- Can you share an experience where facing a difficulty helped you grow or see things differently?
- Who or what do you turn to for support during tough times, and how does that help you? Assessment participant unit: Adult family caregiver participants and optional youth participants.
Analytical level: Salient driving factors of resilience.
Measured: Baseline and six months post-randomization.
Effectiveness Outcome: Family Functioning
Measure: It will be assessed using the Brief Assessment of Family Functioning Scale (BAFFS), which comprises three items rated on a 4-point Likert scale (1 = Strongly Agree, 2 = Agree, 3 = Disagree, and 4 = Strongly Disagree).
Assessment participant unit: Adult family caregiver participants and optional youth participants.
Analytical level: The total score of the BAFFS. As family functioning's categories (construct) based on total BAFFS score: a) Satisfaction with family functioning: BAFFS ≤ 6. b) Family distress: BAFFS > 6.
Measured: Baseline and six month post-randomization.
Effectiveness Outcome: Driving Factors of Family Functioning
Measure: Driving factors of family functioning related to support and cohesion, roles and problem-solving, and the program contributing to family functioning will be assessed with qualitative questions:
- What kinds of support do family members provide to each other?
- How are responsibilities and problem-solving roles shared within your family?
- How does it contribute to family functioning?
- How has your family's functioning changed, if at all, because of participating in this program?
- In what ways do you think your family relationships, communication, or other factors [such as social support, stress, or cultural values] have influenced these changes or your experience with the program? Assessment participant unit: Adult family caregiver participants and optional youth participants.
Analytical level: Salient driving factors of family functioning.
Measured: Baseline and six months post-randomization for questions 1 to 3. Six months post-randomization for questions 4 and 5.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Jun 2026
- Study start20 May 2026
- Primary completion31 Mar 2027 (estimated)
- Study completion30 Sep 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (20)Papers the sponsor has linked to this study.
- Other trials for Diabete Type 2Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- The investigators propose a pilot Hybrid Type 2 Effectiveness-Implementation study (HEI) with a Randomized Controlled Trial (RCT) (1:1) design with a mixed-methods data collection and analysis approach.
- Masking
- None (open label)
- Enrolment
- 140 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Trillium Health Partners
- Sponsor type
- University, hospital or other
- Collaborators
- Sun Life Financial Movement Disorders Research and Rehabilitation Centre
- Responsible party
- Sponsor
- Investigators
- Ian Zenlea, MD, MPH, Principal investigator, Institute for Better Health, Trillium Health Partners, Mississauga.
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07675551
- Sponsor's protocol ID
- THP-RID#00532
- Acronym
- Peel FDPP
- Status last verified
- Sep 2026
- First submitted
- 1 Jun 2026
- Last updated
- 2 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: External academic researchers and community partners may request access to de-identified study data to conduct secondary analyses, including analyses related to research, implementation, effectiveness, or data synthesis (e.g., meta-analyses). Participant identifiers data will not be shared. Data that can be shared include implementation data, effectiveness data, and socio-demographic data.
Publications
Vaishnavi S, Connor K, Davidson JR. An abbreviated version of the Connor-Davidson Resilience Scale (CD-RISC), the CD-RISC2: psychometric properties and applications in psychopharmacological trials. Psychiatry Res. 2007 Aug 30;152(2-3):293-7. doi: 10.1016/j.psychres.2007.01.006. Epub 2007 Apr 25.
PubMed 17459488Expert Panel on Integrated Pediatric Guideline for Cardiovascular Health and Risk Reduction. Pediatrics. 2012;129:e1111. https://doi.org/10.1542/peds.2012-0210.
Sousa MR, McIntyre T, Martins T, Silva E. Questionário dos Conhecimentos da Diabetes (QCD): propriedades psicométricas. Revista Portuguesa de Saúde Pública. 2015;33:33-41. https://doi.org/10.1016/j.rpsp.2014.07.002.
Harris KM, Hotz VJ. National Longitudinal Study of Adolescent to Adult Health (Add Health) Parent Study: Public Use, [United States], 2015-2017. 2020. https://www.icpsr.umich.edu/web/NACDA/studies/37375/versions/V3. Accessed 12 Nov 2025.
Mansfield AK, Keitner GI, Sheeran T. The Brief Assessment of Family Functioning Scale (BAFFS): a three-item version of the General Functioning Scale of the Family Assessment Device. Psychother Res. 2019 Aug;29(6):824-831. doi: 10.1080/10503307.2017.1422213. Epub 2018 Jan 19.
PubMed 29351729Tennant R, Hiller L, Fishwick R, Platt S, Joseph S, Weich S, Parkinson J, Secker J, Stewart-Brown S. The Warwick-Edinburgh Mental Well-being Scale (WEMWBS): development and UK validation. Health Qual Life Outcomes. 2007 Nov 27;5:63. doi: 10.1186/1477-7525-5-63.
PubMed 18042300Robbins R, Quan SF, Barger LK, Czeisler CA, Fray-Witzer M, Weaver MD, Zhang Y, Redline S, Klerman EB. Self-reported sleep duration and timing: A methodological review of event definitions, context, and timeframe of related questions. Sleep Epidemiol. 2021 Dec;1:100016. doi: 10.1016/j.sleepe.2021.100016. Epub 2021 Nov 25.
PubMed 35761957Coleman KJ, Ngor E, Reynolds K, Quinn VP, Koebnick C, Young DR, Sternfeld B, Sallis RE. Initial validation of an exercise "vital sign" in electronic medical records. Med Sci Sports Exerc. 2012 Nov;44(11):2071-6. doi: 10.1249/MSS.0b013e3182630ec1.
PubMed 22688832Bouchaud CC, Chriqui JR, Slim M, Gouin JP, Plourde H, Cohen TR. A Qualitative Evaluation of a Plate-Method Dietary Self-Monitoring Tool in a Sample of Adults Over 50. Curr Dev Nutr. 2023 Jul 20;7(8):101975. doi: 10.1016/j.cdnut.2023.101975. eCollection 2023 Aug.
PubMed 37600934Venkatesh S, Leal DO, Valdez A, Butler PI, Keenan OE, Montemayor-Gonzalez E. Cooking Well with Diabetes: A Healthy Cooking School for Diabetes Prevention and Management. Nutrients. 2024 Aug 3;16(15):2543. doi: 10.3390/nu16152543.
PubMed 39125422Douketis JD, Paradis G, Keller H, Martineau C. Canadian guidelines for body weight classification in adults: application in clinical practice to screen for overweight and obesity and to assess disease risk. CMAJ. 2005 Apr 12;172(8):995-8. doi: 10.1503/cmaj.045170. No abstract available.
PubMed 15824401Goupil R, Tsuyuki RT, Santesso N, Terenzi KA, Habert J, Cheng G, Gysel SC, Bruneau J, Leung AA, Campbell NRC, Schiffrin EL, Hundemer GL. Hypertension Canada guideline for the diagnosis and treatment of hypertension in adults in primary care. CMAJ. 2025 May 25;197(20):E549-E564. doi: 10.1503/cmaj.241770.
PubMed 40419299Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC Jr, Sperling L, Virani SS, Yeboah J. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 Jun 18;139(25):e1082-e1143. doi: 10.1161/CIR.0000000000000625. Epub 2018 Nov 10.
PubMed 30586774Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011 Dec;128 Suppl 5(Suppl 5):S213-56. doi: 10.1542/peds.2009-2107C. Epub 2011 Nov 14. No abstract available.
PubMed 22084329Pearson GJ, Thanassoulis G, Anderson TJ, Barry AR, Couture P, Dayan N, Francis GA, Genest J, Gregoire J, Grover SA, Gupta M, Hegele RA, Lau D, Leiter LA, Leung AA, Lonn E, Mancini GBJ, Manjoo P, McPherson R, Ngui D, Piche ME, Poirier P, Sievenpiper J, Stone J, Ward R, Wray W. 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults. Can J Cardiol. 2021 Aug;37(8):1129-1150. doi: 10.1016/j.cjca.2021.03.016. Epub 2021 Mar 26.
PubMed 33781847
Study at a glance
From the registry record, last updated by the sponsor on 2 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Peel Family Diabetes Prevention Program (Peel FDPP): Family-Centred Health and Wellness Coaching Pilot Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07675551
- Acronym / sponsor ID
- Peel FDPP / THP-RID#00532
- Conditions
- Diabete Type 2
- Keywords
- Diabetes Risk, Diabetes, Coaching, Intervention, Implementation, Effectiveness, Family, Diet Habits
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 140 participants (estimated)
- Lead sponsor
- Trillium Health PartnersUniversity, hospital or other
- Collaborators
- Sun Life Financial Movement Disorders Research and Rehabilitation Centre
- Study start
- 20 May 2026 (actual)
- Primary completion
- 31 Mar 2027 (estimated)
- Study completion
- 30 Sep 2027 (estimated)
- First posted
- 30 Jun 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this Hybrid Type 2 effectiveness-implementation pilot randomized controlled trial is to assess the feasibility and preliminary effectiveness of a community-based wellness coaching intervention (the intervention) to prevent type 2 diabetes (T2D) among South Asian (SA) and Black African and Caribbean (BAC) communities in the Peel region of Ontario, Canada. The study evaluates the impact of the intervention on reducing diabetes risk and related intermediate outcomes, including biomarkers, anthropometric measures, well-being, knowledge, health behaviours, and family-level outcomes in the study participants.
Study's SA and BAC participants will consist of a primary adult family caregiver aged 18 years or older, who does not have T2D and is not taking pharmacological treatment for blood glucose reduction, and who has children aged 25 or under living in the same household. If the Family caregiver has youth children aged 14 to 25 years residing in the same household, who want to participate in the study, they are welcome to join it but not mandatory. The study aims to generate preliminary evidence on both the implementation and effectiveness of the intervention over a six-month per person period. The overall duration of the study (implementation, effectiveness monitoring an evaluation) will be up to 16 months, from the the start of recruitment in May 2026 to the September 2027, where the intervention delivery for the last participant enrolled in the study will expected to be completed.
Family caregiver participants of each ethno-cultural group (SA and BAC) will be randomly assigned to either the intervention or control arm. During the first six months, participants in the intervention arm will receive biweekly health and wellness coaching delivered by trained community-based coaches, optional group coaching sessions with other participants, weekly motivational messages, and an educational T2D prevention booklet. Participants in the control arm will receive only the educational T2D prevention booklet.
Implementation and effectiveness outcomes will be assessed using a mixed-methods approach, integrating qualitative and quantitative data collected at baseline and at the 6-month post-randomization time point. This approach is intended to generate comprehensive, preliminary evidence on both the implementation and effectiveness components of the health and wellness intervention. Quantitative and mixed-methods analyses will be conducted to provide an integrated understanding of the implementation and effectiveness outcomes studied.
Findings from this pilot trial will inform the design of larger, definitive studies to better assess impact and guide future escalation and/or adaptation.
Results will be disseminated in multiple formats and tailored to diverse audiences, including community partners, local communities, social media, referral pathways, academics, researchers, and decision-makers.
Detailed description
Background: Communities from South Asian (SA) and Black African and Caribbean (BAC) backgrounds in the Peel region of Ontario, Canada, experience disproportionately high rates of type 2 diabetes (T2D). The high prevalence of T2D in these communities is driven by a complex set of interrelated factors, including biological predisposition, environmental, and social/behavioural influences, all of which are shaped by social determinants at the societal, system, area, and individual levels. Based on existing collaborative research conducted in these populations in Peel, as well as input from diverse community partners and Peel organizations serving SA and BAC communities, there is a clear need for more family-focused programming to prevent T2D in these communities, particularly community-led and culturally sensitive approaches.
Objective: To assess the intervention's preliminary implementation and effectiveness. Findings will inform future adaptation of the health and wellness coaching T2D prevention model and support scale-up in larger implementation and effectiveness studies.
Methods: In partnership with local Peel-based community organizations, the research team will recruit 70 SA family (plus optional youth) and 70 BAC family caregivers (plus optional youth) to participate in a Hybrid Type 2 Effectiveness-Implementation Pilot Randomized Controlled Trial (RCT) with a six-month person-level follow-up post-randomization and a mixed-methods approach. Of the 70 participating caregivers (plus optional youth) in each community group, 70 will be randomly allocated (1:1) to the intervention group and 70 to the control group. The overall study duration will be 22 months, spanning from participant recruitment through to completion of primary implementation and effectiveness outcome reporting.
Family caregiver participants (family caregiver plus optional youth) in the intervention group will receive tailored, human-delivered health and wellness coaching for the T2D prevention program over six months, where they will receive biweekly diabetes-focused coaching sessions, supplemented by a monthly group-based coaching session. The intervention group will also receive a co-designed educational booklet on diabetes prevention and a weekly short motivational coaching reminder (via email or text, depending on participant preferences). At the end of the six-month coaching follow-up, participants will complete the study through a coaching closeout assessment session conducted by the team coaches.
The participant in the control group (family caregiver plus optional youth) will receive the same co-designed diabetes prevention booklet as the intervention group but will not receive additional coaching support during the six-month follow-up period. At the end of the person follow-up period, control participants will conclude their participation in the study by completing a survey-based assessment of T2D goal attainment, administered by research team staff.
Primary co-implementation outcomes will include acceptability, appropriateness, reach, adoption (uptake), availability, and fidelity. These outcomes will be assessed through semi-structured qualitative interviews conducted by research staff, supplemented with brief survey-based measures. Reach will be assessed from baseline through the recruitment period, while all other outcomes will be measured at 6 month post-randomization.
Co-effectiveness primary outcomes will include hemoglobin A1c (HbA1c) and quality of life measures. Secondary outcomes will include goal-achievement progress, diabetes knowledge, biomarkers (lipid panel), blood pressure, body weight and adiposity, dietary behaviours, cooking practices, diet-related self-efficacy, healthy food intake patterns, and physical activity, sleep duration, quality, satisfaction, and environmental influencing factors; mental well-being state; perceived stress; resilience; and family functioning. Tertiary outcomes will include the intervention's impact on family well-being. Objective measures (biomarkers, blood pressure, body weight, and adiposity) will be collected in person by research staff at enrolment (T1) and 6 months (T2). All remaining outcomes will be assessed using self-administered surveys with validated scales, structured questions, and qualitative open questions at baseline (T1) and 6 months (T2) from the randomization date.
The investigators will use a mixed-methods, cross-sectional and longitudinal (when applicable) convergence-analytical approach to integrate quantitative and qualitative data and, when possible, identify areas of convergence, complementarity, or divergence across implementation and effectiveness outcomes. Primary effectiveness outcomes will be analyzed using an intention-to-treat approach, accounting for repeated measures and interdependence within family dyads (when family caregiver and optional youth) when applicable, and variation in person-time follow-up. The investigators will estimate and report observed effect sizes, along with their corresponding 95% confidence intervals, for all outcomes using descriptive statistics and mixed-effects models or Generalized Estimating Equations, when appropriate. Secondary analyses will further explore potential complex, interrelated associations between implementation and effectiveness outcomes, as well as the influence of socio-demographic and other factors on these relationships. For qualitative data, the investigators will apply one point or Qualitative Longitudinal Research (when two points data are available) approaches to analyze repeated qualitative data collected for both implementation and effectiveness components. Finally, the investigators will conduct a mixed-methods analysis, integrating findings from both qualitative and quantitative strands to assess their alignment, divergence, or complementarity.
Findings: Both implementation and effectiveness findings will be reported, contributing important evidence on the feasibility, delivery and impact of the piloted health and wellness coaching intervention for T2D prevention among SA and BAC family caregiver plus optional youth (when applicable). These findings will help assess future study feasibility, refinements to the intervention model and implementation approach, as well as provide preliminary estimates of potential impact across primary, secondary, and tertiary health-related indicators. Investigators will also assess whether the proposed theory of change is supported, specifically whether the intervention contributes to reducing T2D risk and improving quality of life by supporting participant- and family-tailored diabetes prevention goals, and whether it influences intermediate drivers of T2D risk.
Conclusion: The findings and methodological approach of the pilot-tested proposed intervention will guide the design of larger-scale implementation and effectiveness studies across the same or different communities and settings to further assess its real impact on reducing T2D risk and the main driving factors associated with it.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- The investigators propose a pilot Hybrid Type 2 Effectiveness-Implementation study (HEI) with a Randomized Controlled Trial (RCT) (1:1) design with a mixed-methods data collection and analysis approach.
| Arm | Type | Receives |
|---|---|---|
| Diabetes-Prevention Health and Wellness Coaching | Experimental | Behavioral: Family Dyad Health and Wellness Coaching Session, Behavioral: Educational MaterialFamily caregiver participants (family carrgiver plus optional youth) will take part in an active health and wellness coaching program type 2 diabetes (T2D) prevention, delivered over six-month. Participants will receive 1) biweekly health and wellness coaching sessions (in-person or virtual) provided by trained community-based coaches (maximum session length will be 30 minutes); 2) Receive a short weekly "motivational message" which will be delivered to their phone or email; 3) Join optional monthly group-based health and wellness coaching sessions with other program participants (session length will be 2 hours); and 4) Receive an educational booklet for T2D prevention. |
| Diabetes-Prevention Booklet | Active comparator | Behavioral: Educational MaterialParticipants (family caregivers plus optional youth) will receive the same educational type 2 diabetes (T2D) prevention booklets as the Diabetes-Prevention Health and Wellness Coaching group. Participants from the Diabetes-Prevention Booklet group will be asked to use the T2D educational booklet at their own pace, set up their own T2D prevention goals, and independently access available health promotion, diabetes prevention, and social support services listed in the workbook throughout the 12-month study period. The Diabetes-Prevention Booklet group will not receive coaching sessions, motivational messages, group-based coaching sessions, or any additional diabetes-related guidance from the study's intervention coaches or research team. |
Who may qualify
- Ages
- 14 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (8 listed)
- Study participants will consist of a self-identified primary family caregiver aged 18 years or older with children under 25 year of age living in the same household. Optional youth family member aged 14 to 25 years at the time of study entry are welcome but not mandatory. The primary family caregiver will serve as the primary (index) research participant for the study and should have the following inclusion criteria:
- Self-identifies as either South Asian or Black, African and Caribbean.
- Lives in the Peel Region (Mississauga, Brampton or Caledon), Ontario, Canada.
- Be 18 years or older and have children aged 25 years or under in the same household. AND
- Have no medical diagnosis (self-reported) of diabetes.
Key exclusion criteria (3 listed)
- Do not meet all the criteria above.
- A medical condition or health professional has advised them not to engage in physical activity of any type, or they are following a specific diet.
- Cannot give informed consent to participate voluntarily in the intervention and study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Family Dyad Health and Wellness Coaching SessionBiweekly health and wellness coaching sessions (in-person or virtual) for type 2 diabetes, provided by trained community-based coaches. The maximum session length will be 30 minutes, with no mandatory minimum. Coaches will also share a short weekly motivational message, delivered to participants' phones or emails, depending on preferences. The intervention group participants may join an optional monthly group-based health and wellness coaching session with other program participants. Group sessions will be approximately 2 hours in length. | Behavioural | Diabetes-Prevention Health and Wellness Coaching |
| Educational MaterialA printed or digital educational booklet on type 2 diabetes (T2D) prevention. The booklet contains information related to the causes and signs of T2D, diet and physical activity engagement activities, mental well-being enhancement and stress management, strategies to set up positive lifestyles and behavioural change, along with a list of local health and social support services that may be used to further promote overall well-being and support T2D risk reduction. | Behavioural | Diabetes-Prevention Booklet, Diabetes-Prevention Health and Wellness Coaching |
Primary outcome
Implementation Outcome: Intervention Acceptability
Time frame: Six months post-randomization.
Definition: The perception among our intervention participants (SA and BAC) and coaches that the delivery of the intervention curriculum is agreeable, palatable, or satisfactory. Level and unit of analysis: At the provider (coaches) and study participant level. Measure: Level of rating and perceived intervention's approval, appeal, likeness, and welcoming. Data will be collected from intervention participants and study coaches using semi-structured interviews and surveys. Interviews will use open-ended questions to explore perceived acceptability, including appropriateness, appeal, likeability, and a sense of welcome. Acceptability will also be measured using the 4-item Acceptability of Intervention Measure (AIM), rated on a 5-point Likert scale ranging from 1 (completely disagree) to 5 (completely agree), with higher scores indicating greater acceptability.
Implementation Outcome: Intervention Appropriateness
Time frame: Six months post-randomization.
Definition: The perceived fit, relevance, or compatibility among our intervention participants and coaches (frontline intervention providers) of the intervention content and format in addressing their needs for T2D prevention associated with T2D risk factors. Level and unit of analysis: At the provider (coaches) and study participants' level. Measure: Level of rating and perceived fit, relevance, compatibility, suitability, and usefulness. Data collection and instruments: Data collected through individual semi-structured interviews and surveys. Interviews will explore perceived fit, relevance, compatibility, suitability, usefulness and practicality of the intervention content and format. The survey includes a 4-item Acceptability scale with a 1-5 score (1 = Completely disagree, 2 = Disagree, 3 = Neither agree nor disagree, 4 = Agree, 5 = Completely agree), as well as qualitative questions.
Implementation Outcome: Intervention Reach
Time frame: Baseline.
Definition: The proportion of and representation of the targeted SA and BAC participants in the intervention. Level and unit of analysis: At the study participant level. Measure: Reach rates and related factors. Data collection and instruments: Measured as the reach rate of the targeted population (percentage of eligible families with children aged 25 years or under in Peel of BAC and SA communities that were enrolled in the study), and the percentage of representativeness of the enrolled participants in relation to the SA and BAC population as related to socio-demographic and T2D risk. Qualitative questions exploring drivers of participation will be assessed at screening and enrolment using the expression of interest form, eligibility assessment form, and/or consent form. For example, participants will be asked: "What motivated you to participate in this study?"
Implementation Outcome: Intervention Adoption (Uptake)
Time frame: Six months post-randomization.
Definition: The decision or effort to begin using/implementing the plans/advice from the coaches. Level and unit of analysis: At the study participant level. Measure: Level of rating and perceived intervention's approval, appeal, likeness, and welcoming. Data collection and instruments: Quantitative measures will include enrolment rates; initial uptake (defined as the proportion of intervention participants and family dyads attending at least two sessions within the first month of enrolment); uptake at the end of the active intervention stage; and uptake at the end of the sustainability stage. Qualitative data will be collected through interviews using open-ended questions to explore reasons for enrolment, initiation of the health and wellness T2D coaching intervention, and factors influencing participation, adherence, and completion.
Implementation Outcome: Intervention Availability
Time frame: Six months post-randomization.
Definition: The extent to which the intervention is supplied and accessible at any given time. Level and unit of analysis: At the provider (coaches) and study participant level. Measure: Level of availability and perceived accessibility. Data collection and instruments: Data will be obtained from quantitative measures derived from study and intervention delivery logs at the coach and site levels, as well as from individual semi-structured interviews (accessibility perceptions and driving factors) with the study's intervention coaches and participants in the intervention group. Examples of specific measures: 1) Percentage of participants able to access a session within the first month of enrolment (randomization); 2) Attendance rates at scheduled sessions; 3) Percentage of participants reporting satisfaction with program availability; and 4) Number of last-minute cancellations by participants (participant-related diverse reasons).
Implementation Outcome: Intervention Fidelity
Time frame: Six months post-randomization.
Definition: The degree to which the intervention was consistently implemented as planned. Level and unit of analysis: At the provider (coaches) and study participant level. Measure: Level of fidelity and driving factors. Data collection and instruments: Quantitative/qualitative measures using intervention delivery logging, fidelity checklist, audio-recorded coaches' sessions, and semi-structured interviews. Measures include 1) A self-fidelity score (based on a self-reported fidelity checklist collected after each coaching session). 2) External-fidelity monitoring. A trained independent assessor will also evaluate intervention delivery logs and a sample (10-20%) audio-recorded coaching sessions to determine a fidelity score on a 0-100 scale for the following dimensions: a) Adherence /Content delivered, b) Dose/Dose delivered and received; and c) Coaching Delivery Quality (competence delivery).
Effectiveness Outcome: T2D Risk
Time frame: Baseline and six months post-randomization.
Measure: 1)Capillary Blood Hemoglobin A1C (%), measured using Point-of-care (POC) A1C testing. Assessment participant unit: Adult family caregiver participants and optional youth participants. Analytical level: 1) As a quantitative (continuous) outcome measure (%); and 2) as a clinically significant range (Non-prediabetic (non-prediabetic diabetic): A1C <6.0%. Prediabetes: A1C between 6.0% and <6.5%. Diabetes: A1C > 6.5%).
Effectiveness Outcome: Overall Quality of Life
Time frame: Baseline and six months post-randomization.
Measure: 1) Overall quality of life (QoL) will be assessed using the EQ-5D-5L tool. The EQ-5D-5L measures five dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression), each rated on a 5-level scale (1 = no problems to 5 = extreme problems). Assessment participant unit: Adult family caregiver participants and optional youth participants. Analytical level: 1) The EQ-5D-5L overall health index score. 2) The EQ-5D-5L dimension-specific scores.
Effectiveness Outcome: Health-Related Quality of Life
Time frame: Baseline and six months post-randomization.
Measure: It will be measured using the EQ VAS, whose values range from 0 to 100, reflecting overall health (0 = worst imaginable health; 100 = best imaginable health). Assessment participant unit: Adult family caregiver participants and optional youth participants. Analytical level: Overall health rated score of the EQ VAS.
Effectiveness Outcome: Health-attached QoL Meaning and Perceptions
Time frame: Baseline and six months post-randomization.
Measure: The perceived level of health-related quality of life (QoL) will be assessed using qualitative questions, such as: 1. When you think about health, what does it personally mean to you, and how does that meaning relate to the number you selected on the health scale (EQ-VAS)? 2. Can you explain why you chose that number on the health scale (EQ-VAS) today? 3. What aspects of your health, daily life, or overall well-being influenced your rating? Assessment participant unit: Adult family caregiver participants and optional youth participants. Analytical level: Salient findings will be derived from qualitative data.
Effectiveness Outcome: Happiness
Time frame: Baseline and six months post-randomization.
Measure: 1) Well-being will be assessed using the VAS-Happiness Scale, with a value range of 0 to 100 (0 = completely unhappy, 100 = completely happy). 2) A qualitative happiness assessment using open-ended questions will complement the VAS-Happiness Scale, exploring participants' perceptions of the meaning and interpretation of VAS-Happiness Scale score selection. Assessment participant unit: Adult family caregiver participants and optional youth participants. Analytical level: 1) Overall VAS-Happiness score; and 2) Salient qualitative happiness themes (definition and driving scoring factors).
Effectiveness Outcome: Happiness Meaning and Perceptions
Time frame: Baseline and six months post-randomization.
Measure: It will be assessed using qualitative questions to help participants contextualize their happiness rating level and express their unique perceptions. Qualitative questions that will be used are as follows: 1) When you think about happiness, what does it personally mean to you, and how does that meaning relate to the number you selected on the scale? 2) Can you describe what influenced your rating on the happiness scale today? Assessment participant unit: Adult family caregiver participants and optional youth participants. Analytical level: Salient happiness definition and driving scoring factors.
25 secondary outcomes
Effectiveness Outcome: Diabetes Prevention Knowledge
Time frame: Baseline and six months post-randomization.
Effectiveness Outcome: Intervention Contribution to Diabetes Knowledge
Time frame: Six months post-randomization.
Effectiveness Outcome: Lipids
Time frame: Baseline and six months post-randomization.
Effectiveness Outcome: Blood Pressure
Time frame: Baseline and six months post-randomization.
Effectiveness Outcome: Body Weight
Time frame: Baseline and six months post-randomization.
Effectiveness Outcome: Waist Circumference
Time frame: Baseline and six months post-randomization.
Effectiveness Outcome: Body Mass Index
Time frame: Baseline and six months post-randomization.
Effectiveness Outcome: Diet Cooking Practices Behaviours
Time frame: Baseline and six months post-randomization.
Effectiveness Outcome: Healthy Food Preparation Driven Factors
Time frame: Baseline and six months post-randomization.
Effectiveness Outcome: Self-efficacy in Cooking
Time frame: Baseline and six months post-randomization.
Effectiveness Outcome: Factors Influencing Cooking Self-efficacy
Time frame: Baseline and six months post-randomization.
Effectiveness outcome: Healthy Food Intake
Time frame: Baseline and six months post-randomization.
Effectiveness Outcome: Driving Factors of Healthy Foods Intake Patterns
Time frame: Baseline and six months post-randomization.
Effectiveness Outcome: Physical Activity
Time frame: Baseline and six months post-randomization.
Effectiveness Outcome: Driving Factors of Physical Activity Engagement
Time frame: Baseline and six months post-randomization for questions 1 to 3. Six months post-randomization for question 4.
Effectiveness Outcome: Sleep Duration Behaviour
Time frame: Baseline and six months post-randomization.
Effectiveness outcome: Sleep Quality, Satisfaction, Environmental Influential Factors
Time frame: Baseline and six months post-randomization.
Effectiveness outcome: Mental/Emotional Well-Being
Time frame: Baseline and six months post-randomization.
Effectiveness Outcome: Driving Factors of Mental Well-being
Time frame: Baseline and six months post-randomization for questions 1 to 3. Six months post-randomization for question 4.
Effectiveness Outcome: Perceived Stress
Time frame: Baseline, six months post-randomization, and twelve months post-randomization
Effectiveness Outcome: Driving Factors of Stress
Time frame: Baseline and six months post-randomization for questions 1 to 3. Six months post-randomization for questions 4 and 5.
Effectiveness outcome: Resilience
Time frame: Baseline and six months post-randomization.
Effectiveness Outcome: Driving Factors of Resilience
Time frame: Baseline and six months post-randomization.
Effectiveness Outcome: Family Functioning
Time frame: Baseline and six month post-randomization.
Effectiveness Outcome: Driving Factors of Family Functioning
Time frame: Baseline and six months post-randomization for questions 1 to 3. Six months post-randomization for questions 4 and 5.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Oct 2026.
- Background: PubMed 17459488Vaishnavi S, Connor K, Davidson JR. An abbreviated version of the Connor-Davidson Resilience Scale (CD-RISC), the CD-RISC2: psychometric properties and applications in psychopharmacological trials. Psychiatry Res. 2007 Aug 30;152(2-3):293-7. doi: 10.1016/j.psychres.2007.01.006. Epub 2007 Apr 25.
- BackgroundExpert Panel on Integrated Pediatric Guideline for Cardiovascular Health and Risk Reduction. Pediatrics. 2012;129:e1111. https://doi.org/10.1542/peds.2012-0210.
- BackgroundSousa MR, McIntyre T, Martins T, Silva E. Questionário dos Conhecimentos da Diabetes (QCD): propriedades psicométricas. Revista Portuguesa de Saúde Pública. 2015;33:33-41. https://doi.org/10.1016/j.rpsp.2014.07.002.
- BackgroundHarris KM, Hotz VJ. National Longitudinal Study of Adolescent to Adult Health (Add Health) Parent Study: Public Use, [United States], 2015-2017. 2020. https://www.icpsr.umich.edu/web/NACDA/studies/37375/versions/V3. Accessed 12 Nov 2025.
- Background: PubMed 29351729Mansfield AK, Keitner GI, Sheeran T. The Brief Assessment of Family Functioning Scale (BAFFS): a three-item version of the General Functioning Scale of the Family Assessment Device. Psychother Res. 2019 Aug;29(6):824-831. doi: 10.1080/10503307.2017.1422213. Epub 2018 Jan 19.
- Background: PubMed 18042300Tennant R, Hiller L, Fishwick R, Platt S, Joseph S, Weich S, Parkinson J, Secker J, Stewart-Brown S. The Warwick-Edinburgh Mental Well-being Scale (WEMWBS): development and UK validation. Health Qual Life Outcomes. 2007 Nov 27;5:63. doi: 10.1186/1477-7525-5-63.
- Background: PubMed 35761957Robbins R, Quan SF, Barger LK, Czeisler CA, Fray-Witzer M, Weaver MD, Zhang Y, Redline S, Klerman EB. Self-reported sleep duration and timing: A methodological review of event definitions, context, and timeframe of related questions. Sleep Epidemiol. 2021 Dec;1:100016. doi: 10.1016/j.sleepe.2021.100016. Epub 2021 Nov 25.
- Background: PubMed 22688832Coleman KJ, Ngor E, Reynolds K, Quinn VP, Koebnick C, Young DR, Sternfeld B, Sallis RE. Initial validation of an exercise "vital sign" in electronic medical records. Med Sci Sports Exerc. 2012 Nov;44(11):2071-6. doi: 10.1249/MSS.0b013e3182630ec1.
- Background: PubMed 37600934Bouchaud CC, Chriqui JR, Slim M, Gouin JP, Plourde H, Cohen TR. A Qualitative Evaluation of a Plate-Method Dietary Self-Monitoring Tool in a Sample of Adults Over 50. Curr Dev Nutr. 2023 Jul 20;7(8):101975. doi: 10.1016/j.cdnut.2023.101975. eCollection 2023 Aug.
- Background: PubMed 39125422Venkatesh S, Leal DO, Valdez A, Butler PI, Keenan OE, Montemayor-Gonzalez E. Cooking Well with Diabetes: A Healthy Cooking School for Diabetes Prevention and Management. Nutrients. 2024 Aug 3;16(15):2543. doi: 10.3390/nu16152543.
- Background: PubMed 15824401Douketis JD, Paradis G, Keller H, Martineau C. Canadian guidelines for body weight classification in adults: application in clinical practice to screen for overweight and obesity and to assess disease risk. CMAJ. 2005 Apr 12;172(8):995-8. doi: 10.1503/cmaj.045170. No abstract available.
- Background: PubMed 40419299Goupil R, Tsuyuki RT, Santesso N, Terenzi KA, Habert J, Cheng G, Gysel SC, Bruneau J, Leung AA, Campbell NRC, Schiffrin EL, Hundemer GL. Hypertension Canada guideline for the diagnosis and treatment of hypertension in adults in primary care. CMAJ. 2025 May 25;197(20):E549-E564. doi: 10.1503/cmaj.241770.
- Individual participant dataSharing planned: Yes. External academic researchers and community partners may request access to de-identified study data to conduct secondary analyses, including analyses related to research, implementation, effectiveness, or data synthesis (e.g., meta-analyses). Participant identifiers data will not be shared. Data that can be shared include implementation data, effectiveness data, and socio-demographic data.
Related trials for Diabete Type 2
Active, not recruitingPhase 2
Islet Cell Transplant for Type 1 Diabetes
Type 1 Diabetes Mellitus
Active, not recruitingPhase 4
Diabetes in African Youth
type1diabetes
Active, not recruiting
Metabolic and Inflammatory Outcomes of the Ketogenic Diet Comparing Saturated and Unsaturated Fat Sources
PreDiabetes, Diabetes Mellitus, Type 2
RecruitingObservational study
Washed Microbiota Transplantation for Type 1 Diabetes Mellitus
Type 1 Diabetes
Recruiting
Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Cilia Mejia-Lancheros (Study Research Lead), RN, MPH, Msc. GHP, PhD contact
Ian Zenlea, MD, MPH principal investigator
Institute for Better Health, Trillium Health Partners, Mississauga.
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Family Dyad Health and Wellness Coaching Session and Educational Material in people with Diabete Type 2, run by Trillium Health Partners at 2 sites in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 2 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Cilia Mejia-Lancheros (Study Research Lead), RN, MPH, Msc. GHP, PhD (437 216 6209, Cilia.Mejia-Lancheros@thp.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Implementation Outcome: Intervention Acceptability (time frame: Six months post-randomization.). The study lists 12 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07675551, which also lists 20 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Oct 2026; AzTrials last refreshed its copy on 26 Oct 2026.